CD83 and primary cutaneous T-cell non-Hodgkin lymphoma: While previous reports suggest an abundance of immature dendritic cells in advanced CTCL lesions implicated in tumor progression (39), DC-1 highly expressed the maturation marker CD83 (Figure 5A).